Outset Medical price target raised to $21 from $14 at RBC Capital

RBC Capital raised the firm’s price target on Outset Medical (OM) to $21 from $14 and keeps a Sector Perform rating on the shares after having hosted a fireside chat with the company’s CFO and other executives at the 2025 RBC Global Healthcare Conference. The firm remains “encouraged” by Outset’s progress, but remains on the sidelines until it sees consistency in results, says the analyst, who is applying a higher multiple to reflect the company’s latest business performance aided by improved execution and commercial efforts.